Devin Razavi‐Shearer
About
In The Last Decade
Devin Razavi‐Shearer
26 papers receiving 500 citations
Peers
Comparison fields: 5 of 49
- Hepatology 429
- Epidemiology 419
- Infectious Diseases 95
- Oncology 27
- General Health Professions 15
Countries citing papers authored by Devin Razavi‐Shearer
This map shows the geographic impact of Devin Razavi‐Shearer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devin Razavi‐Shearer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devin Razavi‐Shearer more than expected).
Fields of papers citing papers by Devin Razavi‐Shearer
This network shows the impact of papers produced by Devin Razavi‐Shearer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devin Razavi‐Shearer. The network helps show where Devin Razavi‐Shearer may publish in the future.
Co-authorship network of co-authors of Devin Razavi‐Shearer
This figure shows the co-authorship network connecting the top 25 collaborators of Devin Razavi‐Shearer. A scholar is included among the top collaborators of Devin Razavi‐Shearer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devin Razavi‐Shearer. Devin Razavi‐Shearer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 17 | |
| 7 | 14 | |
| 8 | 3 | |
| 9 | 4 | |
| 10 | 19 | |
| 11 | 7 | |
| 12 | 184 | |
| 13 | 20 | |
| 14 | 79 | |
| 15 | 4 | |
| 16 | HEPATITIS B ELIMINATION IN BRAZIL: REVISITING THE CURRENT STRATEGY | 0 |
| 17 | 1 | |
| 18 | 37 | |
| 19 | 6 | |
| 20 | The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms. | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.